Defects in Coagulation Factors Leading to Recurrent Pregnancy Loss

No abstract is available for this paper.

• Publication year

  2020

• Venue

  Recurrent Pregnancy Loss

• Publication date

  2020-02-12

• Fields of study

  Medicine

• Identifiers
  DOI 10.1201/9780429450303-9
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Improving care and treatment options for women and girls with bleeding disorders

  2015cited by this paper
• Factor XIII (FXIII) and angiogenesis

  2006cited by this paper
• Fetomaternal cross talk in the placental vascular bed: control of coagulation by trophoblast cells.

  2006cited by this paper
• Safety, pharmacokinetics, and immunogenicity of single‐dose rFXIII administration to healthy volunteers

  2005cited by this paper
• Thrombophilia and pregnancy.

  2005cited by this paper
• Short-term effects of estrogen, tamoxifen and raloxifene on hemostasis: a randomized-controlled study and review of the literature.

  2005cited by this paper
• Mechanisms of OC related thrombosis.

  2005cited by this paper
• Spontaneous fetal loss caused by placental thrombosis in estrogen sulfotransferase—deficient mice

  2005cited by this paper
• Thrombophilias and recurrent pregnancy loss: a critical appraisal of the literature.

  2005cited by this paper
• Modulation of cytokine production by dydrogesterone in lymphocytes from women with recurrent miscarriage

  2005cited by this paper
• Prevalence of circulating procoagulant microparticles in women with recurrent miscarriage: a case-controlled study.

  2004cited by this paper
• Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder.

  2004cited by this paper
• The common prothrombotic factors in nulliparous women do not compromise blood flow in the feto-maternal circulation and are not associated with preeclampsia or intrauterine growth restriction.

  2004cited by this paper
• Adverse effects of lupus anticoagulant positive blood sera on placental viability can be prevented by heparin in vitro.

  2004cited by this paper
• Thromboprophylaxis improves the live birth rate in women with consecutive recurrent miscarriages and hereditary thrombophilia

  2003cited by this paper
• Congenital Thrombophilic States Associated with Venous Thrombosis: A Qualitative Overview and Proposed Classification System

  2003cited by this paper
• Factor XIII A subunit-deficient mice developed severe uterine bleeding events and subsequent spontaneous miscarriages.

  2003cited by this paper
• Progestin-regulated expression of tissue factor in decidual cells: implications in endometrial hemostasis, menstruation and angiogenesis.

  2003cited by this paper
• Thrombophilic disorders and fetal loss: a meta-analysis.

  2003cited by this paper
• Aberrations in Placental Cytokine mRNA Related to Intrauterine Growth Retardation

  2002cited by this paper
• Hereditary thrombophilias are not associated with a decreased live birth rate in women with recurrent miscarriage.

  2002cited by this paper
• How strong is the association between maternal thrombophilia and adverse pregnancy outcome? A systematic review.

  2002cited by this paper
• Thrombophilia is common in women with idiopathic pregnancy loss and is associated with late pregnancy wastage.

  2002cited by this paper
• The Expressions of Intracellular Cytokines in the Lymphocytes of Preeclamptic Patients

  2002cited by this paper
• Absence of association of thrombophilia polymorphisms with intrauterine growth restriction.

  2002cited by this paper
• Third‐Trimester Unexplained Intrauterine Fetal Death Is Associated With Inherited Thrombophilia

  2001cited by this paper
• Circulating Procoagulant Microparticles in Women with Unexplained Pregnancy Loss: a New Insight

  2001cited by this paper
• Pathologic Features of the Placenta in Women With Severe Pregnancy Complications and Thrombophilia

  2001cited by this paper
• Factor XII but not protein C, protein S, antithrombin III, or factor XIII is a predictor of recurrent miscarriage.

  2001cited by this paper
• Genetic susceptibility to venous thrombosis.

  2001cited by this paper
• Bleeding risk and reproductive capacity among patients with factor XIII deficiency: a case presentation and review of the literature.

  2000cited by this paper
• Hyperhomocysteinemia and recurrent early pregnancy loss: a meta-analysis.

  2000cited by this paper
• Inherited thrombophilia and fetal loss.

  2000cited by this paper
• Maternal blood coagulation factor XIII is associated with the development of cytotrophoblastic shell.

  2000cited by this paper
• Do placental lesions reflect thrombophilia state in women with adverse pregnancy outcome?

  2000cited by this paper
• Anti‐idiotype immunomodulation of experimental anti‐phospholipid syndrome via effect on Th1/Th2 expression

  1999cited by this paper
• Genotype/phenotype correlations for coagulation factor XIII: specific normal polymorphisms are associated with high or low factor XIII specific activity.

  1999cited by this paper
• Increased frequency of genetic thrombophilia in women with complications of pregnancy.

  1999cited by this paper
• Dysfibrinogenemia and Thrombosis

  1999cited by this paper
• The tumor necrosis factor α and its soluble receptor profile in term and preterm parturition

  1999cited by this paper
• Thrombophilic Polymorphisms Are Common in Women with Fetal Loss without Apparent Cause

  1999cited by this paper
• Case-control Study of the Frequency of Thrombophilic Disorders in Couples with Late Foetal Loss and no Thrombotic Antecedent

  1999cited by this paper
• The Role of Apoptosis in Normal and Abnormal Embryonic Development

  1999cited by this paper
• Activated Protein C Resistance (FV:Q506) and Pregnancy

  1999cited by this paper
• FACTOR XIII DEFICIENCY

  1999cited by this paper
• Thrombophilia: a mechanism of disease in women with adverse pregnancy outcome and thrombotic lesions in the placenta.

  1998cited by this paper
• Low-dose low-molecular-weight heparin is anti-inflammatory during venous thrombosis.

  1998cited by this paper
• Effect of Human Chorionic Gonadotropin on Cytokine Production from Human Endometrial Cells in Vitro

  1998cited by this paper
• Inhibitory effects of low molecular weight heparin on mediator release by mast cells: preferential inhibition of cytokine production and mast cell‐dependent cutaneous inflammation

  1997cited by this paper
• Factor V Leiden Is Associated with Repeated and Recurrent Unexplained Fetal Losses

  1997cited by this paper
• INCREASED FETAL LOSS IN WOMEN WITH HERITABLE THROMBOPHILIA

  1997cited by this paper
• Protein S is inducible by interleukin 4 in T cells and inhibits lymphoid cell procoagulant activity.

  1997cited by this paper
• Fibrinogen Otago: a major α chain truncation associated with severe hypofibrinogenaemia and recurrent miscarriage

  1997cited by this paper
• Novel aspects of blood coagulation factor XIII. I. Structure, distribution, activation, and function.

  1996cited by this paper
• The Risk of Abortion and Stillbirth in Antithrombin-, Protein C-, and Protein S-deficient Women

  1996cited by this paper
• Resolution of spontaneous bleeding events but failure of pregnancy in fibrinogen-deficient mice.

  1995cited by this paper
• Hemostatic factors according to menopausal status and use of hormone replacement therapy.

  1992cited by this paper
• Monoclonal antiphospholipid antibody reactivity against human placental trophoblast.

  1992cited by this paper
• Fibrinogen anomalies and disease. A clinical update.

  1992cited by this paper
• On the binding of tumor necrosis factor (TNF) to heparin and the release in vivo of the TNF-binding protein I by heparin.

  1991cited by this paper
• Fibrinolysis and factor XIII in women with spontaneous abortion.

  1990cited by this paper
• Understanding physicians' response to AIDS.

  1989cited by this paper
• Gonadal steroids modulate human monocyte interleukin-1 (IL-1) activity**Supported in part by National Institutes of Health grant HD 12289.

  1988cited by this paper
• Congenital hypofibrinogenemia and pregnancy, obstetric and hematological management.

  1988cited by this paper
• First report of case of congenital afibrinogenemia with successful delivery.

  1985cited by this paper
• Haemostasis in Normal Pregnancy

  1984cited by this paper
• Cross-linking of fibronectin to collagen by blood coagulation Factor XIIIa.

  1979cited by this paper
• Congenital abnormalities of fibrinogen.

  1979cited by this paper
• CELL SURFACE AND EXTRACELLULAR MATRIX GLYCOPROTEIN FIBRONECTIN: EXPRESSION IN EMBRYOGENESIS AND IN TERATOCARCINOMA DIFFERENTIATION *

  1978cited by this paper
• Simplified classification of spontaneous abortions.

  1978cited by this paper

• Recurrent Pregnancy Loss

  2025cites this paper
• Female reproductive tract microbiome and early miscarriages

  2022cites this paper